These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 7511668)
1. Autoreactive epitope profiles of the proliferating cell nuclear antigen define two classes of autoantibodies. Brand SR; Bernstein RM; Mathews MB J Immunol; 1994 Apr; 152(8):4120-8. PubMed ID: 7511668 [TBL] [Abstract][Full Text] [Related]
2. Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody. Ogata K; Ogata Y; Takasaki Y; Tan EM J Immunol; 1987 Nov; 139(9):2942-6. PubMed ID: 2444646 [TBL] [Abstract][Full Text] [Related]
3. Trimeric structure of human proliferating cell nuclear antigen. Implications for enzymatic function and autoantibody recognition. Brand SR; Bernstein RM; Mathews MB J Immunol; 1994 Oct; 153(7):3070-8. PubMed ID: 7522248 [TBL] [Abstract][Full Text] [Related]
4. Influence of free thiol group(s) on autoantibody-defined epitope of proliferating cell nuclear antigen. Tsai WM; Roos G; Hugli TE; Tan EM J Immunol; 1992 Sep; 149(6):2227-33. PubMed ID: 1381402 [TBL] [Abstract][Full Text] [Related]
5. Autoimmune responses to proliferating cell nuclear antigen multiprotein complexes involved in cell proliferation are strongly associated with their structure and biologic function in patients with systemic lupus erythematosus. Kogure T; Takasaki Y; Takeuchi K; Yamada H; Nawata M; Ikeda K; Matsushita M; Matsudaira R; Kaneda K; Terasawa K; Hashimoto H Arthritis Rheum; 2002 Nov; 46(11):2946-56. PubMed ID: 12428236 [TBL] [Abstract][Full Text] [Related]
6. Relationships between autoantibody responses to deletion mutants of Ki antigen and clinical manifestations of lupus. Matsudaira R; Takeuchi K; Takasaki Y; Yano T; Matsushita M; Hashimoto H J Rheumatol; 2003 Jun; 30(6):1208-14. PubMed ID: 12784391 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies. Roos G; Landberg G; Huff JP; Houghten R; Takasaki Y; Tan EM Lab Invest; 1993 Feb; 68(2):204-10. PubMed ID: 7680082 [TBL] [Abstract][Full Text] [Related]
8. Autoantigenic epitopes of the B and D polypeptides of the U1 snRNP. Analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera. Hirakata M; Craft J; Hardin JA J Immunol; 1993 Apr; 150(8 Pt 1):3592-601. PubMed ID: 7682245 [TBL] [Abstract][Full Text] [Related]
9. A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. Riemekasten G; Marell J; Trebeljahr G; Klein R; Hausdorf G; Häupl T; Schneider-Mergener J; Burmester GR; Hiepe F J Clin Invest; 1998 Aug; 102(4):754-63. PubMed ID: 9710444 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune response to proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connective tissue diseases. Kaneda K; Takasaki Y; Takeuchi K; Yamada H; Nawata M; Matsushita M; Matsudaira R; Ikeda K; Yamanaka K; Hashimoto H J Rheumatol; 2004 Nov; 31(11):2142-50. PubMed ID: 15517625 [TBL] [Abstract][Full Text] [Related]
11. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to human nuclear lamin B2 protein. Epitope specificity in different autoimmune diseases. Brito J; Biamonti G; Caporali R; Montecucco C J Immunol; 1994 Sep; 153(5):2268-77. PubMed ID: 7519647 [TBL] [Abstract][Full Text] [Related]
13. Glyceraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multiprotein complexes in lupus patients. Takasaki Y; Kaneda K; Matsushita M; Yamada H; Nawata M; Matsudaira R; Asano M; Mineki R; Shindo N; Hashimoto H Int Immunol; 2004 Sep; 16(9):1295-304. PubMed ID: 15262899 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins. Fabien N; Moreira A; Lavergne JP; Desbos A; Surgey P; Alves de Olivera C; Gonzalo P; Venot A; Bienvenu J; Perrier H; Reboud JP; Monier JC J Autoimmun; 1999 Aug; 13(1):103-10. PubMed ID: 10441174 [TBL] [Abstract][Full Text] [Related]
15. Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods. Mahler M; Silverman ED; Fritzler MJ Lupus; 2010 Nov; 19(13):1527-33. PubMed ID: 20647252 [TBL] [Abstract][Full Text] [Related]
16. Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies. Ogata K; Ogata Y; Nakamura RM; Tan EM J Immunol; 1985 Oct; 135(4):2623-7. PubMed ID: 2863307 [TBL] [Abstract][Full Text] [Related]
17. Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products. Huff JP; Roos G; Peebles CL; Houghten R; Sullivan KF; Tan EM J Exp Med; 1990 Aug; 172(2):419-29. PubMed ID: 1695666 [TBL] [Abstract][Full Text] [Related]